Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Learn more about Marcello and his recap of 2022 at GenomSys and his outlook for 2023 for himself and the company through the following quick questions:

Good morning Marcello and happy New Year. Starting off easy, which fun-fact did you learn this year?
GenomSys - Marcello

I recently discovered the existence of a really funny satirical prize called the ‘Ig Nobel Prize’, which, unlike the more serious Nobel prize award ceremony, is given for the craziest and seemingly meaningless scientific achievements. They make you laugh but, at the same time, make you think. While many of the awards are tongue-in-cheek, the discoveries are recognized and published in real scientific journals. After laughing at the absurdity, they raise awareness amongst a broader audience for science which is a good thing.

What was your most outstanding achievement at GenomSys in 2022?

This year at GenomSys, along with the rest of the bioinformatics team, we have been working on expanding the features and functionality of GenomSys Variant Analyzer, our primary analysis software for genomic testing. The achievement of this goal has been possible due to the fact that, as a team, we have been able to combine our unique set of skills and experience quickly, which in turn has given a boost to the professional growth of the entire group.

What was the most important thing you learned in 2022?

As I have been working in the past in academia, joining a start-up was a very rewarding and challenging experience. Before joining GenomSys, as an academic researcher, my work usually ended once it was published in a scientific journal or conference. Now I learned to put into action whatever I developed in a fast, reliable way, transforming an analysis pipeline into an ideally remotely accessible and easy-to-use clinical tool. This also gave me the opportunity to learn several aspects of the software development process that I didn’t experience before and realize the importance of teamwork.

What are your expectations for you and/or GenomSys for 2023?

We have new tools currently under development, which we plan to release soon, so I expect the team to finalize the process and start interacting with customers as much as possible. At the same time, I hope to keep learning new techniques and improving my skills.

If you have any further questions for Marcello or about GenomSys, please feel free to contact us.

Schedule a call

[contact-form-7 id="224" title="contact call"]